Oncology & Cancer
Skin cancer in people of color
Dark skin does provide some protection against the sun's ultraviolet rays, but it's a myth that people with dark skin tones are immune to the harmful effects of UV radiation.
May 3, 2022
0
4
Melanoma
Oncology & Cancer
Many pathologists agree overdiagnosis of skin cancer happens, but don't change diagnosis behavior
As the most serious type of skin cancer, a melanoma diagnosis carries emotional, financial and medical consequences. That's why recent studies finding that there is an overdiagnosis of melanoma are a significant cause for ...
May 2, 2022
0
2
Oncology & Cancer
Researchers use CRISPR to build melanoma models from scratch using human cells
By introducing cancer-causing mutations into healthy skin cells step-by-step, Broad scientists have created models of skin cancer that can reveal the effects of mutations.
Apr 29, 2022
0
42
Oncology & Cancer
Can a blood test help diagnose skin cancer?
New research in Advanced NanoBiomed Research indicates that testing an individual's blood can reveal the presence of circulating melanoma cells. Such tests may allow patients to forego invasive skin biopsies to determine ...
Apr 20, 2022
0
9
Oncology & Cancer
Scientists discover gene mutation that signals aggressive melanoma
Mutation of a gene called ARID2 plays a role in increasing the chance that melanoma, a deadly skin cancer, will turn dangerously metastatic, Mount Sinai researchers report.
Apr 18, 2022
0
83
Oncology & Cancer
Exploring cancer maps
Melanoma is a somewhat unusual cancer—one that blooms before our very eyes, often on sun-exposed skin, and can quickly become deadly as it turns our own skin against us and spreads to other organs.
Apr 14, 2022
0
52
Oncology & Cancer
Primary care-based screening ups thin melanoma detection
Primary care-based melanoma screening is associated with increased detection of thin melanomas, according to a study published online April 6 in JAMA Dermatology.
Apr 6, 2022
0
4
Oncology & Cancer
Global burden of melanoma considerable, set to rise by 2040
The global burden of melanoma is considerable and is expected to increase by 2040, according to a study published online March 30 in JAMA Dermatology.
Mar 30, 2022
0
2
Medications
Update shows relatlimab + nivolumab slows advanced melanoma
For patients with previously untreated metastatic or unresectable melanoma, the combination of relatlimab + nivolumab continues to demonstrate a progression-free survival (PFS) benefit over nivolumab alone, according to updated ...
Mar 21, 2022
0
13
Oncology & Cancer
Researchers perform comprehensive analysis of cellular and molecular characteristics of acral melanoma
Acral melanoma is a rare subtype that represents roughly 3% of all melanoma cases. Unlike typical melanoma that occurs on sun-exposed skin, acral melanoma develops on the nonhair bearing skin of the soles, palm and nail beds. ...
Mar 11, 2022
0
68
